Integral Molecular · 4 months ago
Product Manager
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies. They are seeking an entry-level Product Manager to support and grow their Cell Surface Bio product line, blending sales operations, e-commerce management, and strategic product development.
Biotechnology
Responsibilities
Oversee e-commerce operations by ensuring accurate product listings, addressing platform issues, processing manual orders, and ensuring accurate order handling
Manage customer communication and sales support by responding to inquiries, scheduling calls, and overseeing quotes and orders for both catalog and custom antibody products
Support lead generation and outreach efforts by identifying new leads through publication research and targeted outreach and email campaigns in collaboration with marketing
Leverage customer insights, market trends, and competitive analysis to shape product strategy and uncover growth opportunities
Coordinate with scientific, legal, finance, and operations teams to support timely and accurate product and project delivery
Maintain internal documentation and recommend improvements to workflows and system tools
Support product planning by analyzing customer feedback and contributing to pricing, positioning, and roadmap development
Qualification
Required
Bachelor's or Master's in life sciences (PhD applicants interested in transitioning to marketing are welcome)
0–3 years of experience in product management, marketing, sales operations, or scientific commercialization
Strong written and verbal communicator, able to translate technical content into market-facing strategy
Comfortable using tools like e-commerce platforms, CRMs, Excel/Sheets, or basic analytics dashboards
Curious, analytical, and organized, eager to manage complexity and solve customer problems
A proactive collaborator who thrives in fast-paced, team-driven environments
Company
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Funding
Current Stage
Growth StageTotal Funding
$21.42MKey Investors
National Institutes of HealthRedevelopment Assistance Capital Program (RACP)
2024-10-23Grant· $8M
2023-10-05Grant· $0.9M
2023-06-21Grant· $1M
Recent News
Company data provided by crunchbase